Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The healthcare services provider post third-quarter adjusted earnings of $7.15 a share, beating analysts' estimates of $7.

UnitedHealth Posts Earnings Beat. Why the Stock Is Falling.

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.

UnitedHealth Beats But Reins In Outlook As Costs Rise; UNH Stock Slips

UnitedHealth's stock took a hit in early trading Tuesday, after the healthcare giant beat third-quarter profit and revenue expectations but missed on medical-care profitability and lowered its full-year outlook.

UnitedHealth's stock drops as medical costs climb and profit outlook was lowered

UnitedHealth Group reported a better-than-expected profit for the third quarter on Tuesday, aided by expansion of its insurance and Optum businesses.

UnitedHealth beats profit estimates as memberships across businesses expand

--(BUSINESS WIRE)--UnitedHealth Group Reports Third Quarter 2024 Results.

UnitedHealth Group Reports Third Quarter 2024 Results

Costco

Value stocks can stabilize your portfolio growth over time.

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

UnitedHealth Group (UNH) will report third-quarter earnings before the opening bell Tuesday, with investors likely to be watching for continued growth from its Optum division.

What You Need To Know Ahead of UnitedHealth's Earnings

UnitedHealth Group Incorporated's Q3 earnings report is due October 15th. We expect sustained gross income from a favorable insurance pricing environment. However, claims remain unpredictable. Lower interest rates, tight credit spreads, and compressed SOFRs provide an enhanced asset-liability outlook.

UnitedHealth's Q3 Earnings Preview: A Tactical Opportunity Of Note

CVS Health

Humana

Rival healthcare providers could gain from the cut in stars rating for Humana's Medicare plans.

Humana Stock Slumps. CVS and UnitedHealth Could Pick Up the Pieces.

UnitedHealth Group (NYSE: UNH) is scheduled to report its Q2 2024 results on Tuesday, October 15. We expect UnitedHealth to post revenue of $99 billion and earnings of $6.95 on a per-share and adjusted basis, slightly below the street expectations.

What Trends Will Drive UnitedHealth's Q3?

Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Unlocking Q3 Potential of UnitedHealth (UNH): Exploring Wall Street Estimates for Key Metrics

UNH's third-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.

UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold?

CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.

CVS, UnitedHealth ask for FTC's Khan and 2 commissioners to be disqualified from case

In the most recent trading session, UnitedHealth Group (UNH) closed at $583.56, indicating a -1.29% shift from the previous trading day.

Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market

Abbott Labs

Eli Lilly

Investors can find market-trouncing blue chip stocks in the healthcare industry.

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades

--(BUSINESS WIRE)--UnitedHealthcare today announced a $335,000 commitment in funding to Idaho organizations to help close gaps in care among underserved communities, including people in rural areas, individuals with chronic conditions and seniors. “Expanding programs for caregivers, community health workers and providers allows us to address unmet health needs more effectively, helping to ensure that underserved communities access high-quality care and social services they need,” said Dr. Alex.

UnitedHealthcare Commits $335,000 to Idaho Organizations To Expand Health Care Workforce and Access To Care

Humana is diving due to a star-ratings cut for Medicare Advantage plans that will slam 2026 results. UnitedHealth stock is trying to rise.

Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce

--(BUSINESS WIRE)--UnitedHealthcare® today introduced its 2025 Medicare Advantage plans, featuring more choice, broad access to care and stability in the most popular benefits to meet the evolving and varied needs of Medicare consumers. UnitedHealthcare Medicare Advantage plans will continue to reach 96% of Medicare consumers with benefits designed to meet the broad needs of individuals nationally. Highlights of UnitedHealthcare 2025 individual Medicare Advantage plans include: More Coverage Ch.

UnitedHealthcare 2025 Medicare Advantage Plans Deliver Choice, Stability

Centene

October is often a scary period for S&P 500 investors. But it doesn't have to be that way.

12 Stocks Thrive During 'Octoberphobia' Market Crashes

UnitedHealth Group (UNH) concluded the recent trading session at $584.68, signifying a +0.49% move from its prior day's close.

Why UnitedHealth Group (UNH) Outpaced the Stock Market Today

Lockheed Martin

Taiwan Semiconductor Manufacturing

The essence of the "wide moat" investment theme is when businesses possess durable competitive advantages - dubbed moats - that shield them from competitors.

A Closer Look at Wide Moat Stocks

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?

Apple

Amazon

Walmart

U.S. companies have grown significantly over the past five years. Amazon.com is closing in on Walmart for the title of the largest U.S. company.

These Were the 5 Biggest Companies in 2019, and Here Are the 5 Biggest Companies Now

Uber

Great companies can stand the test of time in your portfolio, but every investor will have a different approach to building returns. UnitedHealth Group has had to contend with rising costs lately, but the fundamentals of the business are still excellent.

Got $1,000? 2 Unbelievable Growth Stocks to Buy and Hold Forever

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against UnitedHealth Group Incorporated (NYSE: UNH) on behalf of long-term stockholders following a class action complaint that was filed against UnitedHealth on May 14, 2024 with a Class Period from March 14, 2022 to February 27, 2024. Our investigation concerns whether the board of directors of UnitedHealth have breached their fiduciary duties to the company.

UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating UnitedHealth Group Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

News for UnitedHealth Group Stock (UNH)